245 related articles for article (PubMed ID: 23174107)
1. High aldehyde dehydrogenase activity enhances stem cell features in breast cancer cells by activating hypoxia-inducible factor-2α.
Kim RJ; Park JR; Roh KJ; Choi AR; Kim SR; Kim PH; Yu JH; Lee JW; Ahn SH; Gong G; Hwang JW; Kang KS; Kong G; Sheen YY; Nam JS
Cancer Lett; 2013 Jun; 333(1):18-31. PubMed ID: 23174107
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of aldehyde dehydrogenase (ALDH) activity reduces chemotherapy and radiation resistance of stem-like ALDHhiCD44⁺ human breast cancer cells.
Croker AK; Allan AL
Breast Cancer Res Treat; 2012 May; 133(1):75-87. PubMed ID: 21818590
[TBL] [Abstract][Full Text] [Related]
3. Aldehyde dehydrogenase activity of breast cancer stem cells is primarily due to isoform ALDH1A3 and its expression is predictive of metastasis.
Marcato P; Dean CA; Pan D; Araslanova R; Gillis M; Joshi M; Helyer L; Pan L; Leidal A; Gujar S; Giacomantonio CA; Lee PW
Stem Cells; 2011 Jan; 29(1):32-45. PubMed ID: 21280157
[TBL] [Abstract][Full Text] [Related]
4. Hypoxia-inducible factor-2alpha correlates to distant recurrence and poor outcome in invasive breast cancer.
Helczynska K; Larsson AM; Holmquist Mengelbier L; Bridges E; Fredlund E; Borgquist S; Landberg G; Påhlman S; Jirström K
Cancer Res; 2008 Nov; 68(22):9212-20. PubMed ID: 19010893
[TBL] [Abstract][Full Text] [Related]
5. Hypoxia promotes the phenotypic change of aldehyde dehydrogenase activity of breast cancer stem cells.
Shiraishi A; Tachi K; Essid N; Tsuboi I; Nagano M; Kato T; Yamashita T; Bando H; Hara H; Ohneda O
Cancer Sci; 2017 Mar; 108(3):362-372. PubMed ID: 28012234
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of Wnt1 expression reduces the enrichment of cancer stem cells in a mouse model of breast cancer.
Choi AR; Park JR; Kim RJ; Kim SR; Cho SD; Jung JY; Nam JS
Biochem Biophys Res Commun; 2012 Aug; 425(2):436-42. PubMed ID: 22846569
[TBL] [Abstract][Full Text] [Related]
7. Fibulin-3-mediated inhibition of epithelial-to-mesenchymal transition and self-renewal of ALDH+ lung cancer stem cells through IGF1R signaling.
Kim IG; Kim SY; Choi SI; Lee JH; Kim KC; Cho EW
Oncogene; 2014 Jul; 33(30):3908-17. PubMed ID: 24013232
[TBL] [Abstract][Full Text] [Related]
8. Aldehyde dehydrogenase high gastric cancer stem cells are resistant to chemotherapy.
Nishikawa S; Konno M; Hamabe A; Hasegawa S; Kano Y; Ohta K; Fukusumi T; Sakai D; Kudo T; Haraguchi N; Satoh T; Takiguchi S; Mori M; Doki Y; Ishii H
Int J Oncol; 2013 Apr; 42(4):1437-42. PubMed ID: 23440340
[TBL] [Abstract][Full Text] [Related]
9. Optimized Dosing Schedule Based on Circadian Dynamics of Mouse Breast Cancer Stem Cells Improves the Antitumor Effects of Aldehyde Dehydrogenase Inhibitor.
Matsunaga N; Ogino T; Hara Y; Tanaka T; Koyanagi S; Ohdo S
Cancer Res; 2018 Jul; 78(13):3698-3708. PubMed ID: 29735553
[TBL] [Abstract][Full Text] [Related]
10. [Effect of HIF-2α on the biological characteristics of breast cancer stem cells].
Liu YQ; Li N; Huang HF; Li HX
Zhonghua Yi Xue Za Zhi; 2018 Jan; 98(4):269-273. PubMed ID: 29397612
[No Abstract] [Full Text] [Related]
11. Inhibition of aldehyde dehydrogenase and retinoid signaling induces the expansion of human hematopoietic stem cells.
Chute JP; Muramoto GG; Whitesides J; Colvin M; Safi R; Chao NJ; McDonnell DP
Proc Natl Acad Sci U S A; 2006 Aug; 103(31):11707-12. PubMed ID: 16857736
[TBL] [Abstract][Full Text] [Related]
12. Aldehyde dehydrogenase activity in cancer stem cells from canine mammary carcinoma cell lines.
Michishita M; Akiyoshi R; Suemizu H; Nakagawa T; Sasaki N; Takemitsu H; Arai T; Takahashi K
Vet J; 2012 Aug; 193(2):508-13. PubMed ID: 22326935
[TBL] [Abstract][Full Text] [Related]
13. [Silencing hypoxia inducible factor-2α gene by small interference RNA inhibits the growth of mammosphere cells in nude mice under hypoxic microenvironment].
Qu HB; Fan YM; Han ML; Zeng N; Zhu ZK; Liu H; Xie J; Wu CY; Tang WX
Zhonghua Yi Xue Za Zhi; 2013 Apr; 93(15):1182-7. PubMed ID: 23902893
[TBL] [Abstract][Full Text] [Related]
14. ALDH activity indicates increased tumorigenic cells, but not cancer stem cells, in prostate cancer cell lines.
Yu C; Yao Z; Dai J; Zhang H; Escara-Wilke J; Zhang X; Keller ET
In Vivo; 2011; 25(1):69-76. PubMed ID: 21282737
[TBL] [Abstract][Full Text] [Related]
15. Prospective identification of tumorigenic osteosarcoma cancer stem cells in OS99-1 cells based on high aldehyde dehydrogenase activity.
Wang L; Park P; Zhang H; La Marca F; Lin CY
Int J Cancer; 2011 Jan; 128(2):294-303. PubMed ID: 20309879
[TBL] [Abstract][Full Text] [Related]
16. In Vivo Anti-Tumor Effects of Citral on 4T1 Breast Cancer Cells via Induction of Apoptosis and Downregulation of Aldehyde Dehydrogenase Activity.
Nigjeh SE; Yeap SK; Nordin N; Rahman H; Rosli R
Molecules; 2019 Sep; 24(18):. PubMed ID: 31492037
[TBL] [Abstract][Full Text] [Related]
17. The BMP2/7 heterodimer inhibits the human breast cancer stem cell subpopulation and bone metastases formation.
Buijs JT; van der Horst G; van den Hoogen C; Cheung H; de Rooij B; Kroon J; Petersen M; van Overveld PG; Pelger RC; van der Pluijm G
Oncogene; 2012 Apr; 31(17):2164-74. PubMed ID: 21996751
[TBL] [Abstract][Full Text] [Related]
18. ALDH high adenoid cystic carcinoma cells display cancer stem cell properties and are responsible for mediating metastasis.
Sun S; Wang Z
Biochem Biophys Res Commun; 2010 Jun; 396(4):843-8. PubMed ID: 20450887
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of heat shock protein (Hsp) 27 potentiates the suppressive effect of Hsp90 inhibitors in targeting breast cancer stem-like cells.
Lee CH; Hong HM; Chang YY; Chang WW
Biochimie; 2012 Jun; 94(6):1382-9. PubMed ID: 22445681
[TBL] [Abstract][Full Text] [Related]
20. The noninflammatory role of high mobility group box 1/Toll-like receptor 2 axis in the self-renewal of mammary cancer stem cells.
Conti L; Lanzardo S; Arigoni M; Antonazzo R; Radaelli E; Cantarella D; Calogero RA; Cavallo F
FASEB J; 2013 Dec; 27(12):4731-44. PubMed ID: 23970797
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
